" /> canvaxin - CISMeF





Preferred Label : canvaxin;

MeSH note : a polyvalent vaccine immunotherapy for melanoma of three viable irradiated melanoma cell lines which contain at least 11 known tumor-associated antigens such as MAGE-1, MAGE-3, tyrosinase, gp100, gp75, and Mart-1/Melan-A; increased IgM response in patients receiving vaccine therapy for stage II melanoma was associated with decreased recurrence and improved survival;

Is substance : O;

Détails


Vous pouvez consulter :


Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.